If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,290.00    0.00 (0.00%)
Bid:
2,285.00
Ask:
2,290.00
Spread: 5.00 (0.219%)
Market Cap: £3.09b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

16 May 2024 07:00

RNS Number : 6220O
RIT Capital Partners PLC
16 May 2024
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

 

16 May 2024

 

 

30 April 2024 Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 April 2024 (with debt at fair value) was 2,511p per £1 ordinary share (31 March 2024: 2,536p). This is after deduction of the first interim dividend of 19.5 pence per £1 ordinary share paid on 26 April 2024.

 

April 2024 Highlights

 

US and European equity markets declined in the month of April, with the S&P 500 returning -4.1% in the period and the STOXX Europe 600 returning -0.8%. Global indices also fell, with the MSCI ACWI (50% £) down -2.6% for the month. This was on the back of inflation data in the US coming in higher than anticipated, which caused a shift in market expectations regarding the timing and magnitude of interest rate cuts and led to the 2-year US Treasury yield rising above 5% for the first time since November 2023. Reduced expectations for interest rate cuts in the US saw the US dollar increase by +1% against sterling, while the price of gold reached an all-time high in the middle of April.

 

Our portfolio remained resilient during the month, with a total return of -0.2% in April. This was driven by gains from Private Investments offset by modest declines in our Quoted Equities book, while Uncorrelated Strategies held steady.

 

·

Our Quoted Equities book declined slightly, as healthy gains from certain US listed names and our holdings in China combined with our active portfolio hedging helped to shield the book from weakening in broader equity markets.

 

·

Private Investments were a solid contributor during the month, driven by gains from our private funds which reported updated valuations. As of 30 April, 87% of our private funds were held at 31 December reported valuations and 10% were held at 31 March reported valuations. All private direct holdings are valued at 31 December, in line with our half-yearly valuation process for these holdings.

 

·

Uncorrelated Strategies were resilient, with credit holdings finishing flat and gold positions gaining during the month.

 

·

Currencies also contributed positively during the month, driven by positive translation impacts from the US dollar's increase versus sterling.

 

·

For 2024, RIT has declared a dividend of 39 pence per share, an increase of 2.6% versus 2023 and representing the 10th consecutive year of dividend increases. The first instalment of 19.5 pence was paid on 26 April to shareholders of record on 5 April, and the second instalment will be paid in October 2024.

 

·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. Year to date as of 30 April, the Company has repurchased approximately 1.4 million shares on behalf of shareholders.

 

 

 

 

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDELFFZELLBBE
Date   Source Headline
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 202512:41 pmRNS-RUpdate from QuotedData
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSNet Asset Value(s)
14th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20254:56 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSNet Asset Value(s)
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20254:59 pmRNSHolding(s) in Company
9th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 202510:53 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSNet Asset Value(s)
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202511:21 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
21st Aug 20256:27 pmRNSHolding(s) in Company
18th Aug 20257:00 amRNSNet Asset Value(s)
7th Aug 20257:25 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSHalf-year Report
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20259:47 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.